Antibodies, also known as immunoglobulins (Ig), are proteins with a heterotetrameric structure typically composed of two identical heavy chains (HCs) and two identical light chains (LCs) . These chains are linked by disulfide bridges, forming a Y-shaped molecule . The heavy chains determine the antibody's isotype, such as IgM, IgD, IgA, IgE, and IgG . Each isotype has distinct functions and is identified by its heavy chain type: mu, delta, alpha, epsilon, and gamma, respectively . Light chains are of two types: kappa (κ) and lambda (λ), with each antibody having only one type .
The EN4 monoclonal antibody (MoAb) reacts with the CD31 antigen, also known as PECAM-1 (Platelet Endothelial Cell Adhesion Molecule) . Originally, EN4 was identified as specifically reacting with human endothelial cells, without being assigned to a known CD group . Further characterization revealed that EN4 strongly stains murine fibroblasts transfected with the human CD31 gene .
SDS-PAGE Analysis: Immunoprecipitation of cell lysates from surface-iodinated Jurkat T cells, followed by SDS-PAGE analysis, showed that EN4 and reference CD31 MoAbs recognize the same antigen with a molecular weight of 130 kD .
FACS and Immunohistochemistry: Testing on tonsillar or peripheral blood lymphoid cells via FACS analysis and immunohistochemistry on human tissue sections showed identical reactivity patterns for both EN4 and CD31 antibodies .
Efficiency in Staining: EN4 consistently showed higher efficiency than the reference anti-CD31 MoAb, indicated by more intense fluorescence or tissue staining . This enhanced efficiency allowed for improved characterization of the tissue and cellular distribution of CD31 .
CD31 is a transmembrane glycoprotein expressed on various cell types, including endothelial cells, platelets, and certain leukocytes . It plays a role in cell adhesion, cell signaling, and angiogenesis . The enhanced reactivity of the EN4 antibody makes it a valuable tool for studying CD31 expression and function in different tissues and cellular contexts .
IL-4 is a T cell-derived lymphokine that enhances Ia expression in resting B cells and promotes IgG1 secretion in LPS-activated B cells in vitro . It also regulates in vitro and in vivo polyclonal IgE responses . Studies using anti-IL-4 monoclonal antibodies have demonstrated that IL-4 is essential for generating and sustaining in vivo IgE responses .
Inhibition of IgE Responses: Purified anti-IL-4 mAb can inhibit primary in vivo polyclonal IgE responses by 99% in mice infected with Nippostrongylus brasiliensis or injected with anti-IgD antibodies . It also completely inhibits secondary Ag-specific IgE responses to TNP-keyhole limpet hemocyanin without affecting IgG1 or IgG2a responses to these stimuli .
Effect on B Cell Ia Expression: The anti-IL-4 antibody blocks N. brasiliensis-induced increase in B cell Ia expression by more than 85%, even though in vitro studies suggest that enhancing B cell Ia expression requires less IL-4 than inducing IgG1 secretion .
Sustaining Established IgE Responses: Anti-IL-4 antibody accelerates the decline in total serum IgE and IgE anti-TNP antibody levels when administered at the peak of an IgE response induced by N. brasiliensis or TNP-keyhole limpet hemocyanin .
Thiazolidin-4-one derivatives have demonstrated anticancer activity and are being explored as potential multi-target enzyme inhibitors . These compounds have shown promise in inhibiting various enzymes and cell lines .
CDK2 Inhibition: Compound 2 showed CDK2 inhibitory activity (IC50 = 56.97 ± 2 µM) and cytotoxic activity against MCF-7 and HepG2 tumor cell lines (IC50 values of 0.54 µM and 0.24 µM, respectively) .
Multi-Tyrosine Kinase Inhibition: Compound 4 exhibited multi-tyrosine kinase inhibition against c-Met kinase, Ron, c-Kit, KDR, c-Src, HER-2, IGF-1R, ALK, EGFR, and AXL . It also reduced cell proliferation and induced apoptosis in HT-29, A549, and MDA-MB-231 tumor cell lines .
Activity Against Drug-Resistant Cell Lines: Compounds 4 and 5 inhibited the growth of drug-resistant cell lines A549 DDP and human breast adenocarcinoma (MCF DR) .
In Arabidopsis thaliana, ethylene is perceived by a five-member receptor family: ETR1, ERS1, ETR2, ERS2, and EIN4 .
High-Molecular-Mass Protein Complexes: Ethylene receptors exist as components of high-molecular-mass protein complexes . The ERS1 protein complex shows an ethylene-induced change in size, suggesting ligand-mediated nucleation of protein-protein interactions .
Role of Disulfide Bonds: Disulfide bonds, particularly involving Cys4 and Cys6 of ETR1, stabilize the ETR1 protein complex .
Base Treatment Effects: Treatment with sodium carbonate buffer (pH 10.5) causes a decrease in the molecular mass of the ETR1 complex, indicating the removal of associated proteins .
There are five immunoglobulin classes: IgG, IgM, IgA, IgD, and IgE, each defined by its heavy chain .
IgD: Found in low serum levels, IgD co-expresses with IgM on B cell surfaces, functioning as an antigen-specific BCR and marking B cell differentiation . It may also activate basophils and mast cells for respiratory immune defense .
IgE: With an extra CH domain (CH4), IgE levels are typically low but may increase in inflammatory conditions, parasitic infections, or allergies . IgE binds to Fc receptors on basophils and mast cells, triggering the release of histamine and other compounds that cause allergic reactions .
IgG: The most abundant Ig, IgG has four subclasses in humans, each with varying structural and functional properties due to differences in the hinge and CH2 regions, as well as glycosylation patterns .
EIN4 is a member of the five-member ethylene-receptor family in Arabidopsis thaliana, which includes ETR1, ETR2, EIN4, and ERS1. These receptors play crucial roles in ethylene signaling pathways that regulate numerous plant growth and developmental processes. The EIN4 receptor is particularly important because mutant analyses have shown that the etr1 etr2 ein4 triple mutant exhibits a partial constitutive ethylene-response phenotype, resulting in reduced shoot growth and shorter hypocotyls in air compared to wild-type plants . Understanding EIN4 function provides valuable insights into plant hormone signaling networks, stress responses, and developmental regulation. Antibodies against EIN4 are therefore essential tools for investigating these processes at the molecular level.
EIN4 antibodies are specifically designed to recognize epitopes unique to the EIN4 receptor, distinguishing it from other ethylene receptors like ETR1, ETR2, and ERS1. While all ethylene receptor antibodies can be used to study ethylene signaling, the choice of receptor-specific antibodies depends on the research question. ETR1 antibodies are often used for general ethylene receptor studies due to ETR1's predominant role, while EIN4 antibodies are particularly valuable when investigating receptor subfunctionalization or when the ein4 mutation shows unique phenotypes in combination with other receptor mutations . Researchers should carefully validate cross-reactivity between receptor family members through appropriate controls, as these receptors share conserved domains.
Several methodological approaches can be used for EIN4 detection:
Immunoblotting/Western blot: Most commonly used to detect protein expression levels in tissue extracts. Typical protocols involve:
Tissue extraction with appropriate buffers containing protease inhibitors
Protein separation via SDS-PAGE (typically 8-10% gels)
Transfer to membrane and blocking
Primary incubation with EIN4 antibody (typically 1:1000-1:5000 dilution)
Secondary antibody application and detection
Immunohistochemistry/Immunofluorescence: For localization studies within tissues and cells, similar to techniques used with other receptor antibodies .
Immunoprecipitation: To study protein-protein interactions involving EIN4, following protocols similar to those used for other membrane receptors.
Each method requires optimization of antibody concentration, incubation conditions, and detection systems specific to plant tissues.
Proper validation of EIN4 antibody specificity requires several critical controls:
Genetic controls: Include tissue samples from:
Wild-type plants (positive control)
ein4 knockout/null mutants (negative control)
Plants overexpressing EIN4 (enhanced signal control)
Peptide competition assay: Pre-incubate the antibody with excess EIN4-specific peptide used for immunization to block specific binding sites before application to samples.
Cross-reactivity assessment: Test the antibody against purified recombinant proteins or extracts from plants overexpressing other ethylene receptors (ETR1, ETR2, ERS1) to evaluate potential cross-reactivity.
Secondary antibody-only control: Omit primary antibody to assess non-specific binding of secondary antibody.
These controls should be performed during initial antibody characterization and periodically during experimental use to ensure continued specificity .
Membrane-bound receptors like EIN4 require specialized extraction procedures:
Buffer composition: Use buffers containing:
Mild detergents (0.5-1% Triton X-100 or NP-40)
Protease inhibitor cocktail
Reducing agents (DTT or β-mercaptoethanol)
Phosphatase inhibitors if studying phosphorylation status
Tissue disruption:
For Arabidopsis, grind tissue in liquid nitrogen to fine powder
Maintain cold temperature throughout extraction
Consider ultrasonication for membrane protein solubilization
Subcellular fractionation:
For enrichment of endoplasmic reticulum membranes where ethylene receptors localize
Use density gradient centrifugation methods
Verify fraction purity with appropriate markers
Sample storage:
Prepare fresh samples when possible
If storage is necessary, flash-freeze in liquid nitrogen and store at -80°C
Avoid repeated freeze-thaw cycles
These methods increase detection sensitivity by preserving protein integrity and concentrating membrane-bound receptors .
For successful EIN4 immunoprecipitation:
Crosslinking considerations:
Chemical crosslinkers (DSP, formaldehyde) can stabilize transient interactions
Optimize crosslinking time (typically 10-30 minutes) to prevent over-crosslinking
Include uncrosslinked controls
Antibody coupling:
Direct coupling to beads (e.g., NHS-activated sepharose) often improves results
Use spacer arms for better accessibility to epitopes
Determine optimal antibody:bead ratio (typically 5-10 μg antibody per 50 μl bead slurry)
Washing conditions:
Balance stringency (salt concentration, detergent) against preservation of interactions
Include graduated washes of decreasing stringency
Perform control IPs with non-specific IgG to identify non-specific binding
Elution strategies:
Competitive elution with epitope peptide for mild conditions
Low pH glycine buffers for stronger elution
SDS sample buffer for complete elution
Verification:
Distinguishing between the "on" (ethylene-unbound) and "off" (ethylene-bound) conformations of ethylene receptors like EIN4 is challenging but possible using:
Conformation-specific antibodies:
Proximity-based detection methods:
FRET or BRET-based approaches using fluorescent or bioluminescent tags
Bimolecular fluorescence complementation (BiFC) to visualize interaction-dependent conformational changes
These methods require genetic modification of the receptor
Native versus denaturing conditions:
Some antibodies preferentially recognize native conformations
Compare antibody binding under native versus denaturing conditions
Use non-denaturing PAGE for conformation-dependent detection
Crosslinking-based approaches:
Employ conformation-selective crosslinkers
Analyze crosslinked products by immunoblotting with EIN4 antibodies
These approaches require extensive optimization and validation but provide valuable insights into receptor activation states .
Inconsistent staining with EIN4 antibodies may result from several factors:
| Variable Factor | Troubleshooting Approach | Implementation |
|---|---|---|
| Antibody degradation | Aliquot and store properly | Store at -20°C or -80°C in small aliquots to prevent freeze-thaw cycles |
| Epitope masking | Optimize antigen retrieval | Test different methods (heat, enzymatic, pH-based) for immunohistochemistry |
| Protocol variations | Standardize all steps | Create detailed protocols with precise timing, temperatures, and reagent preparation |
| Sample preparation | Consistent handling | Process all samples identically from collection through fixation |
| Batch variability | Use consistent lots | Record lot numbers and validate each new antibody lot |
| Environmental conditions | Control experimental variables | Maintain consistent temperature, humidity, and timing |
Additionally, include technical replicates and positive controls in each experiment. Consider creating a reference sample batch that can be run alongside experimental samples to calibrate between experiments .
Several advanced techniques can be employed to study EIN4 receptor clustering and dimerization:
Proximity ligation assay (PLA):
Uses pairs of antibodies against the same or different components
Provides visual signals when targets are within 40 nm
Can detect EIN4 homodimers or heterodimers with other ethylene receptors
Quantifiable by fluorescence microscopy
Co-immunoprecipitation (Co-IP) with quantitative analysis:
Pull down with EIN4 antibody and probe for other receptors
Include crosslinking step to capture transient interactions
Use quantitative immunoblotting or mass spectrometry for measurement
Compare ratios under different conditions (e.g., with/without ethylene)
Blue native PAGE:
Preserves protein complexes in their native state
Follow with immunoblotting using EIN4 antibodies
Analyze band sizes to determine complex formation
Compare patterns with/without treatments or in different mutant backgrounds
Förster resonance energy transfer (FRET) with antibodies:
Use fluorescently labeled primary or secondary antibodies
Direct measurement of protein proximity in situ
Requires careful controls for non-specific binding
These methods provide complementary information about receptor interactions and should be used in combination for comprehensive analysis .
Proper quantification and normalization of EIN4 Western blot data requires:
Image acquisition:
Use a wide dynamic range imaging system (e.g., chemiluminescence imager with cooled CCD camera)
Ensure signals are within linear detection range (not saturated)
Take multiple exposures if necessary
Quantification software:
Use specialized software (ImageJ, Image Lab, etc.)
Define lanes and bands consistently
Subtract local background for each band
Normalization approaches:
Loading controls: Normalize to housekeeping proteins (e.g., actin, tubulin, GAPDH)
Total protein normalization: Use stain-free gels or total protein stains (SYPRO Ruby, Ponceau S)
Internal control: Include a reference sample on each gel for inter-gel normalization
Statistical analysis:
Run at least three biological replicates
Perform appropriate statistical tests (t-test, ANOVA)
Report normalized data with error bars and significance values
Validation:
When evaluating EIN4 antibodies, consider these critical criteria:
Validation documentation:
Western blot images showing the expected band size (~77-80 kDa for EIN4)
Evidence of testing in both wild-type and ein4 mutant tissues
Cross-reactivity assessment with other ethylene receptors
Antibody characteristics:
Clearly defined immunogen information (peptide sequence or protein domain)
Production method (monoclonal vs. polyclonal)
Host species and isotype information
Purification method
Application-specific validation:
Tested in your specific application (WB, IHC, IP, etc.)
Optimized protocols for your application
Reported working dilutions and conditions
Independent verification:
Published literature using the same antibody
Positive reviews from other researchers
Alternative antibodies targeting different epitopes for confirmation
Lot-to-lot consistency:
Optical density measurements in antibody-based assays like ELISA require careful interpretation:
Establishing threshold values:
Define positive/negative thresholds using:
ROC curve analysis with known positive/negative samples
Mean + 2-3 SD of negative control samples
Comparison to reference standards
Quantitative interpretation of OD values:
Create standard curves using purified EIN4 protein at known concentrations
Analyze relationship between OD and antigen concentration:
Linear range typically 0.1-2.0 OD units
Sigmoidal relationship across wider ranges
Convert OD to concentration using four-parameter logistic regression
Assessing result reliability:
Include internal controls on each plate
Calculate coefficient of variation (CV) between replicate wells
Consider results reliable when CV < 15%
Understanding relationship to functional assays:
Sources of variability to control:
Incubation timing and temperature
Washing efficiency
Substrate development time
Plate reader calibration and settings
This approach provides more meaningful interpretation beyond simple positive/negative designations .
EIN4 antibodies can provide valuable insights into hormone signaling network integration:
Co-immunoprecipitation studies:
Use EIN4 antibodies to pull down receptor complexes
Analyze precipitates for components of other hormone signaling pathways
Mass spectrometry analysis can identify novel interactors
Western blotting for known components of auxin, cytokinin, or ABA pathways
Proximity-based studies:
Proximity ligation assays (PLA) to visualize interactions in situ
BiFC with split fluorescent proteins to confirm direct interactions
FRET/FLIM using labeled antibodies to measure dynamic interactions
Phosphorylation status analysis:
Immunoprecipitate EIN4 and probe with phospho-specific antibodies
Mass spectrometry to identify phosphorylation sites
Compare phosphorylation patterns after treatment with multiple hormones
Receptor complex dynamics:
Track EIN4-containing complexes during simultaneous hormone treatments
Analyze complex composition changes using Blue Native PAGE followed by immunoblotting
Correlate with physiological responses
These approaches help elucidate how ethylene signaling through EIN4 integrates with other hormone pathways to coordinate plant responses .
For optimal imaging of EIN4 in plant tissues:
Sample preparation optimization:
Fixation: Test aldehydes (4% paraformaldehyde, glutaraldehyde) and compare with freeze substitution methods
Embedding: Paraffin for general histology, LR White resin for better epitope preservation
Sectioning: 5-10 μm sections for light microscopy, 70-100 nm for electron microscopy
Antigen retrieval: Compare heat-induced, enzymatic, and pH-based methods
Immunolabeling strategies:
Direct methods: Directly labeled primary antibodies for simple, one-step detection
Indirect methods: Primary EIN4 antibody followed by labeled secondary antibody for signal amplification
Signal enhancement: Tyramide signal amplification for low-abundance detection
Multiplex labeling: Combine with antibodies against other proteins of interest using different fluorophores
Advanced imaging techniques:
Confocal microscopy: For co-localization studies with other proteins
Super-resolution microscopy: STORM or PALM for nanoscale localization
Immunogold electron microscopy: For ultrastructural localization
Live-cell imaging: Using minimally invasive labeling techniques
Quantitative analysis:
Measure signal intensity across tissues/cells
Analyze co-localization coefficients
Track changes in distribution following treatments
The choice of method depends on the specific research question, with consideration for the subcellular localization of EIN4 in the endoplasmic reticulum membrane .
Bispecific antibody technologies offer powerful approaches for investigating EIN4's interactions:
Generation of bispecific antibodies:
Knobs-into-holes technology: Successfully applied to both IgG1 and IgG4 isotypes
Design considerations: Target epitopes on non-interactive domains of receptors
Production methods: Similar efficiency and quality can be achieved as with standard antibodies
Validation: Confirm binding to both targets individually and simultaneously
Applications in receptor interaction studies:
Co-localization analysis: Use bispecific antibodies targeting EIN4 and another receptor (e.g., ETR1)
Conformational change detection: Design bispecific antibodies that only bind when receptors are in specific conformational states
Functional modulation: Create bispecific antibodies that force or prevent heterodimerization
Quantitative measurements:
Flow cytometry to quantify receptor interactions in protoplasts
FRET-based assays using labeled bispecific antibodies
Surface plasmon resonance for interaction kinetics
In vivo applications:
Microinjection of bispecific antibodies into plant cells
Use cell-penetrating peptides for antibody delivery
Create plant-expressible recombinant antibody fragments
This emerging technology could provide unprecedented insights into the dynamics and functional significance of ethylene receptor interactions .
When facing weak or absent signals in EIN4 Western blots:
| Problem | Possible Causes | Solutions |
|---|---|---|
| No signal | Insufficient protein | Increase sample loading (30-50 μg total protein) |
| Ineffective transfer | Check transfer efficiency with reversible stain | |
| Antibody degradation | Test new antibody aliquot | |
| Weak signal | Low antibody concentration | Optimize primary antibody dilution (try 1:500 - 1:2000) |
| Insufficient incubation | Extend primary antibody incubation (overnight at 4°C) | |
| Inadequate detection system | Switch to more sensitive detection (ECL Plus/Prime) | |
| Membrane type issues | Compare PVDF vs. nitrocellulose membrane performance | |
| High background | Insufficient blocking | Extend blocking time (2 hrs) or try alternative blockers |
| Non-specific binding | Include 0.1% Tween-20 in washing buffers | |
| Secondary antibody issues | Try different secondary antibody or reduce concentration |
Additionally, membrane proteins like EIN4 may require:
Extended denaturation time in sample buffer
Lower temperature transfer conditions
Addition of 0.1% SDS to transfer buffer
When studying EIN4 among the five Arabidopsis ethylene receptors, cross-reactivity can be addressed through:
Antibody selection and optimization:
Choose antibodies raised against unique regions of EIN4
Test antibodies against recombinant proteins of all five receptors
Perform peptide competition assays with EIN4-specific peptides
Genetic approaches:
Use receptor knockout lines as negative controls
Employ transgenic lines with epitope-tagged receptors
Create lines with single receptors complementing quintuple mutants
Technical refinements:
Increase washing stringency (higher salt, detergent concentration)
Pre-absorb antibodies with recombinant proteins of other receptors
Use monoclonal rather than polyclonal antibodies when possible
Data validation:
Compare antibody-based results with genetic evidence
Confirm key findings with orthogonal techniques
Use multiple antibodies targeting different EIN4 epitopes
Advanced specificity testing:
These approaches require significant investment but yield more reliable results when working with closely related proteins .
To maintain EIN4 antibody functionality:
Storage recommendations:
Aliquot antibodies in small volumes (10-50 μl) upon receipt
Store at -20°C for short-term or -80°C for long-term storage
Add stabilizing proteins (BSA, 0.1%) if not already present
Include preservatives (sodium azide, 0.02%) for refrigerated storage
Handling practices:
Avoid repeated freeze-thaw cycles (more than 5)
Thaw on ice and return to storage promptly
Centrifuge briefly after thawing to collect solution
Use sterile technique to prevent contamination
Monitoring antibody quality:
Maintain a reference sample for comparative testing
Document signal intensity across usage time
Test with positive controls before critical experiments
Monitor background levels as indicator of degradation
Regeneration of immunoblotting membranes:
Stripping should be gentle (commercial stripping buffers or 0.2M glycine, pH 2.5)
Limit number of stripping cycles (2-3 maximum)
Re-block thoroughly after stripping
Store stripped membranes at 4°C in TBS with 0.02% sodium azide
Alternative to antibody regeneration:
Cut membranes to probe different regions with different antibodies
Use multiplex fluorescent detection systems
Sequential probing without stripping for non-overlapping proteins
These practices maximize antibody lifespan and ensure consistent performance in research applications .
Single-cell proteomics offers exciting potential for EIN4 research:
Technical approaches for plant single-cell proteomics:
Protoplast isolation followed by microfluidic separation
Laser capture microdissection of specific cell types
Fluorescence-activated cell sorting based on cell-type specific markers
Nanobody-based proximity labeling for subcellular resolution
EIN4 receptor quantification at single-cell level:
Mass cytometry (CyTOF) with metal-labeled EIN4 antibodies
Single-cell Western blotting technologies
Antibody-based microarray platforms
Digital ELISA platforms with single-molecule sensitivity
Data analysis considerations:
Computational approaches for sparse data integration
Trajectory analysis to identify developmental regulation
Correlation with single-cell transcriptomics
Spatial reconstruction of tissue-level patterns
Potential research insights:
Cell-type specific EIN4 expression patterns
Heterogeneity in receptor levels between apparently identical cells
Correlation between receptor abundance and downstream signaling
Dynamic changes during development and stress responses
These approaches would provide unprecedented resolution of ethylene receptor dynamics across different cell types .
Developing conformation-specific antibodies for EIN4 represents an advanced frontier:
Strategic approaches:
Target regions known to undergo conformational changes (based on structural data from ETR1)
Focus on the D25 equivalent region in EIN4, which is critical for ethylene binding in ETR1
Design specific immunization strategies using:
Peptides constrained in active/inactive conformations
Receptors locked in specific states via mutations
Receptor fragments crystallized in defined conformations
Validation methodologies:
Test antibody binding to wild-type vs. constitutively active mutants
Compare binding in presence/absence of ethylene
Use hydrogen-deuterium exchange mass spectrometry to confirm conformational epitopes
Employ molecular dynamics simulations to guide epitope selection
Potential applications:
Real-time monitoring of receptor activation in living tissues
Quantification of active vs. inactive receptor populations
Screening for compounds that modulate receptor conformations
Investigating receptor cross-regulation mechanisms
Technical challenges:
Preserving native membrane protein conformations during immunization
Maintaining conformational epitopes during sample preparation
Distinguishing specific conformational changes from non-specific effects
Standardizing assay conditions for reproducible results
Similar approaches have revolutionized studies of G-protein coupled receptors and could transform our understanding of ethylene perception mechanisms .
Machine learning offers promising avenues for EIN4 antibody research:
Epitope prediction and antibody design:
Deep learning models can predict optimal epitopes for generating receptor-specific antibodies
Sequence-based algorithms can identify regions of maximum divergence between ethylene receptors
Structure-based approaches can target surface-exposed, receptor-specific domains
Biophysics-informed models similar to those used for customized antibody specificity profiles
Optimizing experimental conditions:
Machine learning can identify patterns in successful vs. unsuccessful experiments
Bayesian optimization for efficiently determining optimal antibody concentrations
Neural networks to predict cross-reactivity based on sequence homology
Random forest algorithms to identify critical variables in immunoprecipitation success
Image analysis enhancements:
Convolutional neural networks for automated detection of staining patterns
Segmentation algorithms for quantifying receptor distribution
Classification of cellular phenotypes based on receptor localization
Super-resolution image reconstruction
Integration with multi-omics data:
Correlate antibody-based protein detection with transcriptomics
Predict protein-protein interactions based on co-localization patterns
Model receptor dynamics in different genetic backgrounds
Systems biology approaches to place EIN4 in broader signaling networks
These computational approaches could significantly accelerate discovery and improve reproducibility in EIN4 antibody research .